Literature DB >> 24323128

From genomics to imaging-advances along the care continuum.

Ahmed Haddad1, Yair Lotan1.   

Abstract

2013 saw the publication of several reports providing insight into a range of ongoing issues in bladder cancer, from screening high-risk candidates to using blue-light cystoscopy to reduce recurrence. These data will strengthen efforts to optimize the detection and treatment of bladder cancer, benefiting patients along the cancer continuum.

Entities:  

Mesh：

Year:  2013        PMID： 24323128     DOI： 10.1038/nrurol.2013.286

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


  8 in total

1.  NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

Authors:  Montserrat García-Closas; Núria Malats; Debra Silverman; Mustafa Dosemeci; Manolis Kogevinas; David W Hein; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Gemma Castaño-Vinyals; Meredith Yeager; Robert Welch; Stephen Chanock; Nilanjan Chatterjee; Sholom Wacholder; Claudine Samanic; Montserrat Torà; Francisco Fernández; Francisco X Real; Nathaniel Rothman
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

2.  Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance.

Authors:  Jorg Oddens; Maurizio Brausi; Richard Sylvester; Aldo Bono; Cees van de Beek; George van Andel; Paolo Gontero; Wolfgang Hoeltl; Levent Turkeri; Sandrine Marreaud; Sandra Collette; Willem Oosterlinck
Journal:  Eur Urol       Date:  2012-11-02       Impact factor: 20.096

Review 3.  Statistical consideration for clinical biomarker research in bladder cancer.

Authors:  Shahrokh F Shariat; Yair Lotan; Andrew Vickers; Pierre I Karakiewicz; Bernd J Schmitz-Dräger; Peter J Goebell; Nuria Malats
Journal:  Urol Oncol       Date:  2010 Jul-Aug       Impact factor: 3.498

Review 4.  Epidemiology and risk factors of urothelial bladder cancer.

Authors:  Maximilian Burger; James W F Catto; Guido Dalbagni; H Barton Grossman; Harry Herr; Pierre Karakiewicz; Wassim Kassouf; Lambertus A Kiemeney; Carlo La Vecchia; Shahrokh Shariat; Yair Lotan
Journal:  Eur Urol       Date:  2012-07-25       Impact factor: 20.096

5.  Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer.

Authors:  Montserrat Garcia-Closas; Nathaniel Rothman; Jonine D Figueroa; Ludmila Prokunina-Olsson; Summer S Han; Dalsu Baris; Eric J Jacobs; Nuria Malats; Immaculata De Vivo; Demetrius Albanes; Mark P Purdue; Sapna Sharma; Yi-Ping Fu; Manolis Kogevinas; Zhaoming Wang; Wei Tang; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Alison Johnson; Molly Schwenn; Margaret R Karagas; Alan Schned; Gerald Andriole; Robert Grubb; Amanda Black; Susan M Gapstur; Michael Thun; William Ryan Diver; Stephanie J Weinstein; Jarmo Virtamo; David J Hunter; Neil Caporaso; Maria Teresa Landi; Amy Hutchinson; Laurie Burdett; Kevin B Jacobs; Meredith Yeager; Joseph F Fraumeni; Stephen J Chanock; Debra T Silverman; Nilanjan Chatterjee
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

Review 6.  Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.

Authors:  Maximilian Burger; H Barton Grossman; Michael Droller; Joerg Schmidbauer; Gregers Hermann; Octavian Drăgoescu; Eleanor Ray; Yves Fradet; Alexander Karl; Juan Pablo Burgués; J Alfred Witjes; Arnulf Stenzl; Patrice Jichlinski; Dieter Jocham
Journal:  Eur Urol       Date:  2013-04-08       Impact factor: 20.096

7.  Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer.

Authors:  Gopa Iyer; Hikmat Al-Ahmadie; Nikolaus Schultz; Aphrothiti J Hanrahan; Irina Ostrovnaya; Arjun V Balar; Philip H Kim; Oscar Lin; Nils Weinhold; Chris Sander; Emily C Zabor; Manickam Janakiraman; Ilana R Garcia-Grossman; Adriana Heguy; Agnes Viale; Bernard H Bochner; Victor E Reuter; Dean F Bajorin; Matthew I Milowsky; Barry S Taylor; David B Solit
Journal:  J Clin Oncol       Date:  2013-07-29       Impact factor: 44.544

8.  Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.

Authors:  Yair Lotan; Aditya Bagrodia; Niccolo Passoni; Varun Rachakonda; Payal Kapur; Yull Arriaga; Christian Bolenz; Vitaly Margulis; Ganesh V Raj; Arthur I Sagalowsky; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2013-04-03       Impact factor: 20.096
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.